VC  Signet Healthcare Partners

     Office Locations:

Carnegie Hall Tower
152 West 57th Street, 59th Floor
New York, NY 10019
Phone: 646-840-4990
Fax: 212-419-3956



  • Expansion



  • Life Sciences & Healthcare
  • Medical Device



    Signet Healthcare partners was founded by James Gale and Sanders Morris Harris Group in 1998 with the establishment of the Corporate Opportunities Funds. Since 1998, the firm has organized four funds with aggregate capital commitments in excess of $400 million, and has invested in more than 45 companies. For the past nine years, Signet Healthcare has maintained its dedicated focus to diversified healthcare investing--primarily serving as lead investor to expansion stage companies engaged in specialty pharmaceuticals, medical devices and the pharma services industries. Since inception of Signet's Funds, the firm has invested on a global basis with approximately 20% of its funds committed to entities domiciled in Europe and Asia. Signet is currently making new investments out of its fourth fund, Fund IV. The Fund IV team is comprised of three senior investment professionals and a network of venture partners and operating advisors. A typical investment ranges from $10 million - $15 million per portfolio company.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Arin Bose PhD Advisor
    Ashley Friedman Managing Director
    James C. Gale Founding Partner & Managing Director
    Jerry Liao Vice President
    Nikhil Puri Managing Director


    Portfolio companies include:

      Leading Pharma
        web link


    Recent News: